Hannah L. Rush, MBChB, on Self-Reported Quality of Life in the STAMPEDE Trial

Posted: Tuesday, March 3, 2020

Hannah L. Rush, MBChB, of the Clinical Trials Unit at University College London, discusses data on comparative self-reported quality of life and symptoms, as well as what the literature shows about the adverse events associated with docetaxel vs abiraterone.